Product Description: Rosonabant is a selective antagonist for cannabinoid receptor (CB1 receptor), which reduces body weight and improves improves the risk of obesity-related cardiovascular metabolic diseases. Rosonabant exhibits adverse side effect, such as nausea and mental disorder[1].
Formula: C21H21Cl3N4O
References: [1]Janero DR, et al., Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis. Expert Opin Emerg Drugs. 2009 Mar;14(1):43-65.
CAS Number: 861151-12-4
Molecular Weight: 451.78
Research Area: Metabolic Disease; Cardiovascular Disease
Target: Cannabinoid Receptor